Showing results (261-270 of 1,998) with videos related to

Sort By:
Pageof 200
Endocrine, Metabolic & Immune Disorders Drug Targets|April 1, 2022
The Potential Role of Gut Microbiota in the Pathogenesis of Type 2 Diabetes Mellitus via Epigenetics and InflammasomeBunty Sharma, Aman Kumar, Ujjawal Sharma, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 29, 2018
Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer CellsSaverio M Lepore, Valentina Maggisano, Giovanni E Lombardo, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 6, 2018
Extra-thoracic Extrinsic Compression: An Unusual Cause of DysphagiaSirish C Rao, Anjana Sathyamurthy, Erica P Turse, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 6, 2018
Potential Impact of MicroRNA-423 Gene Variability in Coronary Artery DiseaseChandan K Jha, Rashid Mir, Imadeldin Elfaki, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|October 6, 2018
The Effects of D-aspartate on Neurosteroids, Neurosteroid Receptors, and Inflammatory Mediators in Experimental Autoimmune EncephalomyelitisMahdi Goudarzvand, Yaser Panahi, Reza Yazdani, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 17, 2019
Lepidine B & E as New Target Inhibitors from Lepidium Sativum Seeds Against Four Enzymes of the Pathogen Candida albicans: In Vitro and In Silico StudiesSafia Gacemi, Khedidja Benarous, Santiago Imperial, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|June 26, 2019
Proteomics Screening of Differentially Expressed Cytokines in Tears of Patients with Graves' OphthalmopathyRong-Hua Song, Bin Wang, Qiu-Ming Yao, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 7, 2022
Clinical Correlations of Lipid Profiles with the Age and Gender in the Coronary Artery Disease Patients: A Study of 3878 CAD Patients from IndiaRashid Mir, Imadeldin Elfaki, Ehab A M Frah, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 7, 2022
The Role of Inflammatory and Cytokine Biomarkers in the Pathogenesis of Frailty SyndromeRashid Mir, Chandan K Jha, Naina Khullar, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 4, 2022
Neuroprotective Substances: Are they Able to Protect the Pancreatic Beta- Cells Too?Rita U Ostrovskaya, Sergei V Ivanov
Pageof 200